Document Detail


Bacterial immunotherapy of childhood bronchial asthma.
MedLine Citation:
PMID:  7405764     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In everyday practice, we usually encounter two types of childhood asthma, as regards etiology. On the one hand, primary allergic bacterial asthma and on the other, primary allergic extrinsic asthma; it is rare to encounter other types of asthma in infancy. Our point of vieew, as previously expressed elsewhere, is that the bacterial or infective factor is the most important etiologically. For this reason, we consider of major importance not only antibiotic treatment of the causative agent, but also immunotherapy with bacterial vaccines. Eighty patients were studied, 48 boys and 32 girls, aged between 2 and 10 years at the time immunotherapy was started. All had been diagnosed as having bronchial asthma of exclusively bacterial etiology, with or without associated paranasal sinusitis. In order to provide an objective estimate and evaluation of the efficacy of immunotherapy, the parents of the patients were interviewed and asked to complete the questionnaire shown in figure 1. There were 46 patients whose progress was classified as very good, amounting to 57.5%, 23 patients, or 28.7% had good results. The sume of these two groups was 69 cases, amounting to 86.2%. The remainder (fair, poor, did not complete treatment) amounted to 13.8% or 11 cases. In this last group, the highest proportion made fair progress, with 8 cases (10%). As far as tolerance to bacterial immunotherapy is concerned, in 47 cases, or 58%, no reactions occurred, while in 33 cases, or 41% of the total, side effects were observed. We should like to repeat once again that, on the basis of our results up to now, we consider the administration of appropriate bacterial immunotherapy essential as an etiological treatment in this type of asthma.
Authors:
A Oehling; C E Baena-Cagnani; H Neffen
Related Documents :
17904834 - Predictors of a more favourable response to combined therapy with salmeterol and flutic...
19674354 - Nebulized hypertonic saline/salbutamol solution treatment in hospitalized children with...
2618584 - A possible harmful late effect of methylprednisolone therapy on a time cluster of optic...
15705984 - Endoluminal stenosis of proximal bronchi in sarcoidosis: bronchoscopy, function, and ev...
21435544 - Relationship between the lingual frenulum and craniofacial morphology in adults.
19891054 - Changes in biomarkers of cardiovascular risk after a switch to abacavir in hiv-1-infect...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Allergologia et immunopathologia     Volume:  8     ISSN:  0301-0546     ISO Abbreviation:  Allergol Immunopathol (Madr)     Publication Date:    1980 May-Jun
Date Detail:
Created Date:  1980-10-24     Completed Date:  1980-10-24     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0370073     Medline TA:  Allergol Immunopathol (Madr)     Country:  SPAIN    
Other Details:
Languages:  eng     Pagination:  177-84     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Asthma / etiology,  immunology,  therapy*
Bacterial Infections / complications
Bacterial Vaccines / therapeutic use*
Betamethasone / therapeutic use
Child
Child, Preschool
Female
Humans
Male
Chemical
Reg. No./Substance:
0/Bacterial Vaccines; 378-44-9/Betamethasone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Screening tests for the detection of bladder cancer.
Next Document:  Standardization and regulatory control of allergen extracts.